Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Feb 5;27(1):1073274820904694. doi: 10.1177/1073274820904694

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Expression levels of ROR are positively associated with increased MDR and poor prognosis of patients with gastric cancer. A, The expression of ROR was compared by real-time PCR analyses of the tumor specimens from patients with refractory gastric cancer after chemotherapy (n = 36) and patients with nonrefractory gastric cancer (n = 27), P = .0069. B, Kaplan-Meier survival curves stratified a total of 63 gastric cancer patients according to ROR expression. P = .026 between low ROR (n = 33) and high ROR (n = 30) groups. MDR indicates multidrug resistance; PCR, polymerase chain reaction; ROR, regulator of reprogramming.